Journal

Science immunology
ISSN: 2470-9468
Titre abrégé: Sci Immunol
Pays: United States
ID NLM: 101688624

Informations de publication

Date de publication:
24 May 2024
Historique:
medline: 24 5 2024
pubmed: 24 5 2024
entrez: 24 5 2024
Statut: ppublish

Résumé

Inborn errors of T cell development present a pediatric emergency in which timely curative therapy is informed by molecular diagnosis. In 11 affected patients across four consanguineous kindreds, we detected homozygosity for a single deleterious missense variant in the gene NudC domain-containing 3 (

Identifiants

pubmed: 38787962
doi: 10.1126/sciimmunol.ade5705
doi:

Substances chimiques

RAG-1 protein 128559-51-3
Homeodomain Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eade5705

Auteurs

Rui Chen (R)

Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.

Elena Lukianova (E)

Wellcome Sanger Institute, Wellcome Genome Campus, CB10 1SA Hinxton, UK.

Ina Schim van der Loeff (IS)

Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.
Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, NE1 4LP Newcastle upon Tyne, UK.

Jarmila Stremenova Spegarova (JS)

Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.

Joseph D P Willet (JDP)

Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.

Kieran D James (KD)

Institute of Immunology and Immunotherapy, University of Birmingham. B15 2TT Birmingham, UK.

Edward J Ryder (EJ)

Wellcome Sanger Institute, Wellcome Genome Campus, CB10 1SA Hinxton, UK.

Helen Griffin (H)

Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.

Hanna IJspeert (H)

Department of Immunology, Erasmus University Medical Center, Rotterdam 3000 CA, Netherlands.

Akshada Gajbhiye (A)

Biosciences Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.

Frederic Lamoliatte (F)

Biosciences Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.

Jose L Marin-Rubio (JL)

Biosciences Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.

Lisa Woodbine (L)

Genome Damage and Stability Centre, University of Sussex, BN1 9RQ Brighton, UK.

Henrique Lemos (H)

Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.

David J Swan (DJ)

Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.

Valeria Pintar (V)

Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.

Kamal Sayes (K)

Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.

Elias R Ruiz-Morales (ER)

Wellcome Sanger Institute, Wellcome Genome Campus, CB10 1SA Hinxton, UK.

Simon Eastham (S)

Wellcome Sanger Institute, Wellcome Genome Campus, CB10 1SA Hinxton, UK.

David Dixon (D)

Biosciences Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.

Martin Prete (M)

Wellcome Sanger Institute, Wellcome Genome Campus, CB10 1SA Hinxton, UK.

Elena Prigmore (E)

Wellcome Sanger Institute, Wellcome Genome Campus, CB10 1SA Hinxton, UK.

Penny Jeggo (P)

Genome Damage and Stability Centre, University of Sussex, BN1 9RQ Brighton, UK.

Joan Boyes (J)

Faculty of Biological Sciences, University of Leeds, LS2 9JT Leeds, UK.

Andrew Mellor (A)

Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.

Lei Huang (L)

Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.

Mirjam van der Burg (M)

Department of Immunology, Erasmus University Medical Center, Rotterdam 3000 CA, Netherlands.

Karin R Engelhardt (KR)

Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.

Asbjørg Stray-Pedersen (A)

Norwegian National Unit for Newborn Screening, Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo 0424, Norway.

Hans Christian Erichsen (HC)

Division of Pediatric and Adolescent Medicine, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo 0424, Norway.

Andrew R Gennery (AR)

Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.
Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, NE1 4LP Newcastle upon Tyne, UK.

Matthias Trost (M)

Biosciences Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.

David J Adams (DJ)

Wellcome Sanger Institute, Wellcome Genome Campus, CB10 1SA Hinxton, UK.

Graham Anderson (G)

Institute of Immunology and Immunotherapy, University of Birmingham. B15 2TT Birmingham, UK.

Anna Lorenc (A)

Wellcome Sanger Institute, Wellcome Genome Campus, CB10 1SA Hinxton, UK.

Gosia Trynka (G)

Wellcome Sanger Institute, Wellcome Genome Campus, CB10 1SA Hinxton, UK.
Open Targets, Wellcome Genome Campus, CB10 1SA Hinxton, UK.

Sophie Hambleton (S)

Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.
Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, NE1 4LP Newcastle upon Tyne, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH